Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Tiziana Life Sciences Ltd (TLSA) had Stock-Based Compensation of $3.15M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$12.72M |
|
$0.02M |
|
$3.88M |
|
$16.60M |
|
$7.40M |
|
-- |
|
-- |
|
$7.40M |
|
$9.20M |
|
$9.20M |
|
$9.20M |
|
118.82M |
|
| Cash Flow Statement Financials | |
$-6.82M |
|
$2.88M |
|
$7.36M |
|
$3.72M |
|
$7.25M |
|
$3.53M |
|
|
Stock-Based Compensation |
$3.15M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|